Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Neoplasia (New York, N.Y.)
|
June 9, 2021
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53
Joanna S Yi, Oscar Sias-Garcia, Nicole Nasholm, et al.
Cancer Discovery
|
February 1, 2015
The genetics of splicing in neuroblastoma
Justin Chen, Christopher S Hackett, Shile Zhang, et al.
Cell Reports
|
March 7, 2024
ALK upregulates POSTN and WNT signaling to drive neuroblastoma
Miller Huang, Wanqi Fang, Alvin Farrel, et al.
The Journal of Experimental Medicine
|
July 14, 2025
Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma
Marie Ménard, Hiroyuki Yoda, Nicole Nasholm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2025
The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial
Alison M Schram, Abdul Rafeh Naqash, Eric B Haura, et al.
Cell Reports
|
December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma
Christopher S Hackett, David A Quigley, Robyn A Wong, et al.
Cancer Research
|
January 29, 2021
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers
Adam J Wolpaw, Richard Bayliss, Gabriele Büchel, et al.
Cancer Research
|
September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface
Jessica Koach, Jessica K Holien, Hassina Massudi, et al.
Cancer Cell
|
September 3, 2019
Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse
Liguo Zhang, Xuelian He, Xuezhao Liu, et al.
The Journal of Clinical Investigation
|
December 5, 2017
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
Liying Chen, Gabriela Alexe, Neekesh V Dharia, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Neoplasia (New York, N.Y.)
|
June 9, 2021
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53
Joanna S Yi, Oscar Sias-Garcia, Nicole Nasholm, et al.
Cancer Discovery
|
February 1, 2015
The genetics of splicing in neuroblastoma
Justin Chen, Christopher S Hackett, Shile Zhang, et al.
Cell Reports
|
March 7, 2024
ALK upregulates POSTN and WNT signaling to drive neuroblastoma
Miller Huang, Wanqi Fang, Alvin Farrel, et al.
The Journal of Experimental Medicine
|
July 14, 2025
Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma
Marie Ménard, Hiroyuki Yoda, Nicole Nasholm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2025
The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial
Alison M Schram, Abdul Rafeh Naqash, Eric B Haura, et al.
Cell Reports
|
December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma
Christopher S Hackett, David A Quigley, Robyn A Wong, et al.
Cancer Research
|
January 29, 2021
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers
Adam J Wolpaw, Richard Bayliss, Gabriele Büchel, et al.
Cancer Research
|
September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface
Jessica Koach, Jessica K Holien, Hassina Massudi, et al.
Cancer Cell
|
September 3, 2019
Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse
Liguo Zhang, Xuelian He, Xuezhao Liu, et al.
The Journal of Clinical Investigation
|
December 5, 2017
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
Liying Chen, Gabriela Alexe, Neekesh V Dharia, et al.
Page
of 4